CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 77 enrolled
Drug / intervention
Natural Treatmentdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03830177
NCT03830177Phase 2Completed

Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adults

Ann & Robert H Lurie Children's Hospital of Chicago·interventional·Posted Feb 5, 2019·Updated Feb 24, 2025

In Brief

A Phase 2 clinical trial evaluating Natural Treatment for Dermatitis, Seborrheic and Dry Skin; Eczema. Completed, enrolled 77 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the safety and efficacy of a novel topical treatment for dry scalp conditions, including dandruff, seborrheic dermatitis, and atopic dermatitis. The study investigates clinical improvements in symptom severity, participant experience with the treatment, and changes in the scalp microbiome before and after use. By studying this treatment, the investigators aim to provide children and adults with a natural, effective option for managing dry scalp conditions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedFeb 5, 2019
Enrollment StartJul 8, 2019
Primary CompletionJan 11, 2023
Study CompletionOct 4, 2023
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 7.4 years ago

Interventions

Natural Treatmentdrug

Participants will receive a topical treatment formulated with natural ingredients (Lactobacillus sp., honey, and turmeric) and a kit containing all necessary materials, including an instruction handout. The treatment is applied to the scalp, left for roughly 5 minutes, and rinsed off.